Mink Therapeutics Inc
INKT
NASDAQ
Biotechnology
$11.27
USD
+0.27 (+2.45%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $54.80M
Volume 6.8K
About Mink Therapeutics Inc
The company is headquartered in New York City, New York and currently employs 15 full-time employees. The company went IPO on 2021-10-15.
CEO
Dr. Jennifer Buell
HQ
New York City, NEW YORK, US
Founded
2021
Employees
15
Key Metrics
1 metrics our research team weighs before forming a view on INKT.
Based on Quantli research · SEC filings · as of Q1 2026
METRIC
VALUE
CHANGE
TREND (3Y)
Free Cash Flow (TTM)
$-6.32M
—
Financial Snapshot
Revenue
$0
— YoY
Gross Margin
—
— YoY
Net Income
$-12.47M
-28.1%
YoY
Operating Cash Flow
$-6.32M
+24.4%
YoY
Key Statistics
Open
$11.10
Previous Close
$11.00
Day Range
$10.95 - $11.50
52 Week Range
$8.48 - $18.17
Volume
6.8K
Average Volume (10 Days)
10.0K
Dividend Yield
—
Valuation Measurement
Market Cap
$54.80M
P/E Ratio (TTM)
—
Financial Highlights
Return on Assets
-120.2%
Return on Equity
98.3%
Revenue (TTM)
$0
Net Income (TTM)
$-12.47M
Diluted EPS (TTM)
-$2.83
Total Cash (MRQ)
$9.53M
Levered FCF (TTM)
$-6.32M
Turn research into action
Knowing a stock is strong is the start. Knowing how to invest in it when you spot good research is good returns.
Earnings Calendar
Next Earnings
Estimated Q3 Release
Nov 12
Est. EPS
Adjusted consensus estimate
-$0.64
Analyst Consensus
Based on 1 analyst ratings
Avg Target: $35.00
(+210.6% upside)
High: $35.00 · Low: $35.00
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%